Ariad Pharmaceuticals Inc
ARIA
ARIA was delisted on the 15th of February, 2017.
175 hedge funds and large institutions have $802M invested in Ariad Pharmaceuticals Inc in 2015 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 52 increasing their positions, 62 reducing their positions, and 24 closing their positions.
15% more call options, than puts
Call options by funds: $14.3M | Put options by funds: $12.5M
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
8% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 24
1% less funds holding
Funds holding: 177 → 175 (-2)
16% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 62
31% less capital invested
Capital invested by funds: $1.16B → $802M (-$358M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$86.4M |
| 2 |
HI
HBK Investments
Dallas,
Texas
|
+$7.71M |
| 3 |
DCM
Dynamic Capital Management
St. Helier,
Jersey
|
+$4.5M |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$3.62M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.94M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
Discovery Capital Management
South Norwalk,
Connecticut
|
-$43.9M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$19.7M |
| 3 |
Renaissance Technologies
New York
|
-$16M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$11.6M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.12M |
ARIA Hedge Fund Activity: Q3 2015 in Review
175 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q3 2015, worth a combined $802M — down 31% from $1.16B a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of ARIA and 22 opened new positions — a net loss of 2 holders — while 62 trimmed existing stakes and 52 added.
The largest buyer was Putnam Investments, adding an estimated $86.4M. The largest seller was Discovery Capital Management, exiting entirely with an estimated $43.9M sold.
- 175 institutional investors held Ariad Pharmaceuticals Inc (ARIA) as of Q3 2015, down from 177 in Q2 2015.
- Funds reported $802M of Ariad Pharmaceuticals Inc stock for Q3 2015, down 31% quarter-over-quarter.
- 22 funds opened new Ariad Pharmaceuticals Inc positions in Q3 2015 and 24 closed out, a net change of -2 holders.
- The largest Ariad Pharmaceuticals Inc buyer in Q3 2015 was Putnam Investments, an estimated $86.4M added.
- The largest Ariad Pharmaceuticals Inc seller in Q3 2015 was Discovery Capital Management, an estimated $43.9M sold.
Based on aggregated 13F filings for Q3 2015.